The Canton of Vaud, the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL) and the Ludwig Institute for Cancer…

UCB Farchim, the Swiss subsidiary of Belgian biopharmaceutical group UCB, has announced a major new phase of development for its…

HemostOD, a Swiss Health Valley company pioneering the ex vivo manufacturing of donor-free, off-the-shelf universal human blood platelets, announces the…

A new national initiative, NAIPO (National AI Initiative for Precision Oncology), is set to transform cancer care in Switzerland by…

Two Swiss Health Valley startups supported by Fondation pour l’Innovation Technologique (FIT) are tackling some of healthcare’s most pressing challenges:…

The European investment company listed on Euronext Brussels is thereby becoming a major shareholder. These funds will be used to…

BioArk & New Mexico Venture Studios have established a strategic partnership to support startups in life sciences, medtech, and deep…

Two EPFL-based startups: BioLNP Innovation and OneCell Protein, have become the latest recipients of the EPFL Startup Launchpad Ignition grant….

Global private equity healthcare specialist ARCHIMED acquires a majority stake in family-owned ExcellGene and sister company Magellan Biologics & Consulting (both in the biologic therapeutics sector),…

EPFL spin-off Bioscibex, a biotechnology start-up specialising in bioproduction equipment, has secured CHF 150,000 in funding from Venture Kick. This…

Geneva-based Multiwave Technologies AG has raised CHF 3.6 million (USD 4.5 million) in fresh funding to accelerate the development and…

Vaud-based startup Adaptyv, specializing in the experimental validation of AI-generated proteins, has raised CHF 6,40 million in seed funding. The…